Additively Enhanced Antiproliferative Effect of Interferon Combined with Proanthocyanidin on Bladder Cancer Cells
Authors:
- Blake JohnsonBJBlake Johnson
- Bobby AlexanderBABobby Alexander
- John WonJWJohn Won
- Muhammad ChoudhuryMCMuhammad Choudhury
- Sensuke KonnoSKSensuke Konno
Open Access
- 1 January 2012
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 3, 107-112
Abstract
Although interferon (IFN) has been often used as immunotherapy for bladder cancer, its efficacy is rather unsatisfactory, demanding further improvement. Combination therapy is one of viable options, and grape seed proanthocyanidin (GSP) could be such an agent to be used with IFN because it has been shown to have anticancer activity. We thus investigated whether combination of IFN and GSP might enhance the overall antiproliferative effect on bladder cancer cells in vitro. Human bladder cancer T24 cells were employed and treated with the varying concentrations of recombinant IFN-α2b (0-100,000 IU/ml), GSP (0-100 μg/ml), or their combinations. IFN-α2b alone led to a ~50% growth reduction at 20,000 (20K) IU/ml, which further declined to ~67% at ≥50K IU/ml. Similarly, GSP alone induced a ~35% and ~100% growth reduction at 25 and ≥50 μg/ml, respectively. When IFN-α2b and GSP were then combined, combination of 50K IU/ml IFN-α2b and 25 μg/ml GSP resulted in a drastic >95% growth reduction. Cell cycle analysis indicated that such an enhanced growth inhibition was accompanied by a G1 cell cycle arrest. This was further confirmed by Western blot analysis revealing that expressions of G1-specific cell cycle regulators (CDK2, CDK4, cyclin E and p27/Kip1) were distinctly modulated with such IFN-α2b/GSP treatment. Therefore, these findings support the notion that combination of IFN-α2b and GSP is capable of additively enhancing antiproliferative effect on T24 cells with a G1 cell cycle arrest, implying an adjuvant therapeutic modality for superficial bladder cancer.Keywords
This publication has 23 references indexed in Scilit:
- Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cellsCarcinogenesis, 2005
- Proanthocyanidin from grape seeds enhances anti-tumor effect of doxorubicin both in vitro and in vivo.2005
- Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin‐like growth factor binding protein‐3International Journal of Cancer, 2003
- Interferon-α Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines2003
- Recombinant bacille Calmette–Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicityClinical and Experimental Immunology, 2001
- Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cellsToxicology, 2000
- BCG immunotherapy of bladder cancer: 20 years onThe Lancet, 1999
- Bacillus calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancerUrology, 1996
- Intravesical therapy in superficial bladder cancerUrology, 1994
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991